Fumihiro Tomoda | Cardiology & Nephrology | Best Researcher Award

Prof. Dr. Fumihiro Tomoda | Cardiology & Nephrology | Best Researcher Award

Fukui Health Science University | Japan

Dr. Fumihiro Tomoda is a Japanese physician-scientist specializing in nephrology, hypertension, hemorheology, platelet function, renal microcirculation, glomerular hypertension, and stress hormones. He graduated from the Faculty of Medicine at Toyama Medical and Pharmaceutical University, and from April 2005 until March 2015 served as Senior Researcher in the Second Department of Internal Medicine at that institution. From April 2015 to March 2017 he was Professor at Fukui Health College, and since April 2017 he has held the position of Professor in the Faculty of Health Science at Fukui Health Science University in Fukui, Japan. His research covers multiple interrelated fields: how acute and chronic stress affect sympatho-adrenal activation; how blood viscosity and platelet Behaviour are altered in essential hypertension; how renal microvascular structure and renal hemodynamics respond to hypertension; and how biomarkers such as nerve growth factor may function in hypertension and kidney disease. According to his Research Map profile, he has published at least ~ 46 peer-reviewed articles. However, public sources do not clearly report a definitive h-index or total citations for him as of now. If desired, I can try to retrieve his h-index and citation-count from Scopus or Web of Science.

Profile : Orcid 

Featured Publications 

"Impact of Mild Renal Impairment on the Relationship Between Blood Pressure and Renal Fractional Excretion of Albumin in Primary Hypertension"

"Urinary levels of cortisol but not catecholamines are associated with those of 8-hydroxy-2'-deoxyguanosine in uncomplicated primary hypertension"

"Factors Associating with Non-Dipping Pattern of Nocturnal Blood Pressure in Patients with Essential Hypertension"

"Plasma and Urinary Levels of Nerve Growth Factor Are Elevated in Primary Hypertension"

"Impact of Geriatric Nutritional Risk Index and Modified Creatinine Index Combination on Mortality in Hemodialysis Patients"

Assoc Prof Dr. Hany fayed – kidney injury – liver fibrosis -Best Researcher Award

Assoc Prof Dr. Hany fayed - kidney injury - liver fibrosis -Best Researcher Award

National Research Centre - Egypt

Author Profile

SCOPUS

ORCID

Early academic pursuits 🎓

hany moawad ali fayed embarked on his academic journey with a solid foundation in veterinary medicine. he earned his bachelor’s degree in veterinary medical sciences from menofiya university in 2007, graduating with a very good cumulative grade. his pursuit of advanced knowledge led him to cairo university, where he obtained his master’s degree in veterinary pharmacology in 2013. his master’s thesis explored the hepatoprotective effects of artichoke extract against precancerous lesions in rats. furthering his expertise, he completed his phd in veterinary pharmacology at cairo university in 2017, with his research focusing on evaluating osteopontin in experimentally induced liver fibrosis in rats.

Professional endeavors 🏛️

dr. fayed’s professional career has been marked by his roles in both teaching and research. from 2012 to 2022, he conducted and taught training courses on pharmacological and toxicological experiments and animal handling at cairo university’s faculty of pharmacy. his research career began as an assistant researcher at the national research centre’s department of pharmacology from 2015 to 2018. he then advanced to a researcher position from 2018 to 2023, and has been serving as an associate professor since july 2023. in these roles, he has contributed significantly to various research projects and collaborations, focusing on pharmacology and toxicology.

Contributions and research focus 🔬

dr. fayed’s research contributions are substantial, particularly in the field of pharmacology. he has led and participated in multiple projects, including a study on the therapeutic effects of canagliflozin and linagliptin against hepatocarcinogenesis in rats, funded by the national research centre. his work also includes investigating new therapies for liver fibrosis and hepatoprotective activities of egyptian sansevieria species. his kidney injury - liver fibrosis involvement in nano toxicological and pharmacological assessments of nano gold materials highlights his commitment to advancing cancer diagnosis and therapy.

Accolades and recognition 🏆

dr. fayed has been recognized for his exceptional research and academic contributions. in 2017-2018, he was awarded the national research centre prize for the best phd thesis in the medical division. his active participation in conferences and workshops, including the 14th kidney injury - liver fibrosis international phytocosmetics and phytotherapy congress, further demonstrates his commitment to advancing scientific knowledge and fostering collaboration in his field.

Impact and influence 🌍

dr. fayed’s work has had a significant impact on the field of pharmacology, particularly in the areas of liver disease and cancer research. his research on hepatoprotective agents and liver fibrosis contributes to the development of new therapeutic strategies, while his involvement in kidney injury - liver fibrosis high-profile research projects and conferences helps shape the direction of future studies in pharmacology and toxicology.

Legacy and future contributions 🔮

looking ahead, dr. fayed is poised to continue his impactful work in pharmacology and toxicology. his ongoing projects and research efforts aim to enhance understanding of liver diseases and develop novel therapeutic approaches. his dedication to both research and education ensures that his contributions will have a lasting effect on the field, influencing future research and training in pharmacology and related disciplines.

Notable Publications